12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Company News  |  Other News

Bausch + Lomb ophthalmic news

Bausch + Lomb said that its ISTA Pharmaceuticals Inc. subsidiary will pay about $34 million in civil and criminal fines to the U.S. government to settle litigation involving conduct by ISTA that occurred between January 2006 and March 2011. The subsidiary pled guilty to...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >